- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01731145
Assessment of Tremor Using SNUMAP Motion Sensing System (SNUMAP)
July 7, 2015 updated by: BS Jeon, Seoul National University Hospital
Quantitative Assessment of Tremor Using Portable Six-axis (Tri-axial Accelerometer and Tri-axial Gyroscope) Motion Sensing System
The purpose of this study is to record and measure tremor using portable six-axis (tri-axial accelerometer and tri-axial gyroscope) motion sensing system.
Study Overview
Detailed Description
SNUMAP system is portable, finger-worn, battery powered device that contains MEMS (micro-electro-mechanical system) hybrid motion sensor (three-axis accelerometer and three-axis gyroscope).
The SNUMAP device consists of a wrist module and finger module, which attaches to an patients's finger and transmits three dimensional motions to a wrist module for storage and further analysis.
The aims of this study is to assess tremor severity using tri-axial accelerometry and gyroscope to determine the reliability and the correlation with clinical measurements.
Study Type
Interventional
Enrollment (Actual)
187
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Department of Neurology, Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 20-80 years
- Patients with tremor (involuntary, rhythmic, oscillatory movement in one or more body part)
- Subject who signed an informed consent
Exclusion Criteria:
- Pregnant or nursing woman.
- Comorbid neurologic illnesses that impact the ability to perform the study tasks.
- Subjects with medical condition that in the opinion of the investigator would affect his/her ability to participate in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: SNUMAP assessment
Uses SNUMAP motion sensing system to quantify tremor symptom.
|
Portable six-axis (tri-axial accelerometer and tri-axial gyroscope) motion sensing system
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
3-D Accelerometric and gyroscope variables measured
Time Frame: 1 day
|
Correlation between SNUMAP motion sensing system symptom assessment and clinical tremor rating scale (TRS) scores
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Beom S Jeon, M.D., Ph.D., Seoul National University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2014
Primary Completion (ACTUAL)
February 1, 2015
Study Completion (ACTUAL)
February 1, 2015
Study Registration Dates
First Submitted
November 15, 2012
First Submitted That Met QC Criteria
November 20, 2012
First Posted (ESTIMATE)
November 21, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
July 8, 2015
Last Update Submitted That Met QC Criteria
July 7, 2015
Last Verified
July 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D-1407-011-590
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tremor
-
Emory UniversityCompletedEssential Tremor | Essential Vocal Tremor | Essential Voice Tremor | Voice Tremor | Vocal TremorUnited States
-
KU LeuvenCompleted
-
Syracuse UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedEssential Voice Tremor | Voice Tremor | Vocal Tremor | Essential Tremor of VoiceUnited States
-
Abbott Medical DevicesCompletedEssential Tremor | Tremor | Action Tremor | Tremor, LimbUnited States
-
KU LeuvenCompleted
-
University Hospital, MontpellierCompletedUpper Limb Tremor InvalidatingFrance
-
University Health Network, TorontoNational Organization for Rare DisordersRecruiting
-
ES Therapeutics Australia Pty LtdRecruitingTremor, EssentialCanada
-
University of OxfordWithdrawnEssential Tremor | Dystonic Tremor
-
InSightecActive, not recruitingNeurologic Manifestations | Tremor | Tremor, EssentialKorea, Republic of, Canada